111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-32.44%
Negative 5Y CAGR while JHX stands at 50.77%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-44.51%
Negative 3Y CAGR while JHX stands at 33.53%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
486.80%
Below 50% of JHX's 1436.38%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
2310.96%
3Y OCF/share CAGR above 1.5x JHX's 608.41%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
354.02%
Positive 5Y CAGR while JHX is negative. John Neff might view this as a strong mid-term relative advantage.
-35.62%
Negative 3Y CAGR while JHX is 81.41%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
51.34%
Below 50% of JHX's 464.13%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
46.80%
Below 50% of JHX's 442.65%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
135.88%
Stable or rising mid-term dividends while JHX is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
55.15%
Our short-term dividend growth is positive while JHX cut theirs. John Neff views it as a comparative advantage in shareholder returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.